Simon Evans
Directeur Financier/CFO chez National Pharma Services
Profil
Simon Evans is a former Executive Director & Group Finance Director at Dechra Pharmaceuticals Plc where he worked from 1997 to 2012.
Prior to that, he was the Group Finance Director at National Pharma Services from 1992 to present (current job).
Postes actifs de Simon Evans
| Sociétés | Poste | Début |
|---|---|---|
National Pharma Services
 National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Directeur Financier/CFO | 03/09/2010 |
Anciens postes connus de Simon Evans
| Sociétés | Poste | Fin |
|---|---|---|
| DECHRA PHARMACEUTICALS | Directeur Financier/CFO | 19/10/2012 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Dechra Pharmaceuticals Plc
 Dechra Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Dechra Pharmaceuticals Ltd. is a holding company, which engages in the veterinary pharmaceuticals and related products business. It operates through the following segments: European Pharmaceuticals; North American Pharmaceuticals; and Pharmaceuticals Research and Development. The European Pharmaceuticals segment markets and sells licensed pharmaceuticals and specialist pet foods to the veterinary profession in Europe. The North American Pharmaceuticals segment focuses on the sale of a range of endocrine, ophthalmic, dermatological, and equine products in North America. The Pharmaceuticals Research and Development segment develops and licenses Dechra's own branded veterinary product portfolio of novel and generic pharmaceuticals and specialist pet diets. The company was founded in 1819 and is headquartered in Northwich, the United Kingdom. | Health Technology |
National Pharma Services
National Pharma Services Pharmaceuticals: MajorHealth Technology National Pharma Services provides pharmaceutical services. Martin Riley has been the CEO of the British company since 2005. | Health Technology |
